VIRX Trademark

Trademark Overview

On Wednesday, July 21, 2021, a trademark application was filed for VIRX with the United States Patent and Trademark Office. The USPTO has given the VIRX trademark a serial number of 90840548. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, April 18, 2025. This trademark is owned by SaNOtize Research and Development Corp.. The VIRX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the prevention and treatment of viral diseases
virx

General Information

Serial Number90840548
Word MarkVIRX
Filing DateWednesday, July 21, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, April 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 17, 2022

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention and treatment of viral diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSaNOtize Research and Development Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVancouver V7Y-1B3
CA
Party NameSaNOtize Research and Development Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver V7Y-1B3
CA

Trademark Events

Event DateEvent Description
Saturday, July 24, 2021NEW APPLICATION ENTERED
Wednesday, September 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 14, 2022ASSIGNED TO EXAMINER
Thursday, April 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 27, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 17, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 17, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 10, 2023SOU EXTENSION 1 FILED
Tuesday, January 10, 2023SOU EXTENSION 1 GRANTED
Tuesday, May 9, 2023SOU EXTENSION 2 FILED
Thursday, January 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 9, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 9, 2023SOU EXTENSION 2 GRANTED
Thursday, May 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 9, 2024SOU EXTENSION 3 FILED
Tuesday, January 9, 2024SOU EXTENSION 3 GRANTED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 29, 2024SOU EXTENSION 4 FILED
Monday, April 29, 2024SOU EXTENSION 4 GRANTED
Monday, January 13, 2025SOU EXTENSION 5 FILED
Monday, January 13, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, April 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 17, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 18, 2025SOU EXTENSION 5 GRANTED
Friday, April 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

virx viral diseases treatment prevention products pharmaceutical